Company Provides Update on Operations & EU Commercialization SAN JOSE, Calif., Jan. 15, 2025 /PRNewswire/ -- Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that the Company now has approval to start a pre-market 510k study from the FDA. In...
Read More Details
Finally We wish PressBee provided you with enough information of ( Silver Bullet Therapeutics Announces FDA Approval of Pre-Market Study )
Also on site :
- Ukraine doing West’s ‘dirty work’ in Africa – Sudanese official
- Two people killed by falling trees and thousands without power after storms sweep southern states
- Keanu Reeves Has a Most Excellent ‘Bill & Ted’ Red Carpet Reunion With Costar Alex Winter at the Tony Awards